Citigroup's Geoff Meacham targets $1,600 for LLY, representing 37% upside, anchored by Mounjaro and Zepbound's combined $14.9B single-quarter revenue. Novo Nordisk dropped 8% in one session after its post-Wegovy update disappointed, while Viking Therapeutics carries 207% implied upside on clinical-stage binary risk. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Eli Lilly didn't make the cut.
Enter your email to see the names that beat LLY. Enter your email and see if any of your stocks made the cut. Eli Lilly (NYSE:LLY) currently trades at $1,164.79, while Wall Street's average analyst price target sits at $1,325.39.
That leaves roughly 14% of implied upside between where the stock is and where the consensus says it belongs. Lilly is the dominant force in the GLP-1 obesity and diabetes market, with Mounjaro and Zepbound now generating a combined $14.9 billion in a single quarter. Wall Street watches this stock closely because it is one of the largest healthcare companies in the world, with a market cap near $1.03 trillion, and because its pipeline may decide whether the entire obesity category becomes a multi-decade franchise.
Lilly just wrapped a rough stretch, and one major bank is arguing the selling is overdone. Lilly shares have dropped 7.21% over the past month, sliding from about $1,255.40 to current levels even as the broader market pushed higher. Q2 revenue beat consensus by 11.06% and EPS came in 27.27% above estimates.
Pricing anxiety weighed on the stock. Realized U.S. prices fell 9% excluding rebate adjustments, and international pricing compressed after Mounjaro's inclusion in China's National Reimbursement Drug List. Investors also digested $2.78 billion in acquired IPR&D charges and fresh competitive noise from Novo Nordisk's post-Wegovy strategy update on Monday. 24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now.
Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
Extract — continue reading at the source.
